SDS-PAGE/purity, DNase, RNase, latent RNase, endonuclease.
Recombinant and RNasin® Plus: Recombinant strain of E. coli (Cat.# N2511, N2515, N2611, N2615).
Native: Human placenta (Cat.# N2111, N2115).
20mM HEPES-KOH (pH 7.6 at 4°C), 50mM KCl, 8mM DTT and 50% (v/v) glycerol.
Store at –20°C.
One unit is defined as the amount of RNasin® Ribonuclease Inhibitor required to inhibit the activity of 5ng of ribonuclease A by 50%. Activity is measured by the inhibition of hydrolysis of cytidine 2,3´-cyclic monophosphate by ribonuclease A.
For product intended use please see Patents & Disclaimers tab.
N2111, N2115 For Research Use Only. Not for Use in Diagnostic Procedures.
N2511, N2515, N2611, N2615 For Laboratory Use. Outside of the United States, this product is intended for research use only unless otherwise stated.
Patents - Disclaimers
N2611, N2615 Patent Pending.